The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
AMM:CICO's 9-Day RSI is ranked better than 77.25% of 699
companies
in the Healthcare Providers & Services industry
Industry Median: 47.47
vs AMM:CICO: 33.64
The Consultant & Investment Group (AMM:CICO) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Consultant & Investment Group 9-Day RSI Related Terms
AMM:CICO vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, The Consultant & Investment Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Consultant & Investment Group 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Consultant & Investment Group's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where The Consultant & Investment Group's 9-Day RSI falls into.
The Consultant & Investment Group (AMM:CICO) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group (AMM:CICO) has a 9-Day RSI of 33.64 as of Jun. 29, 2026. According to the industry distribution chart, The Consultant & Investment Group ranks #159 out of 699 companies in the Healthcare Providers & Services industry, placing it in the top 22.7%.
Is The Consultant & Investment Group's 9-Day RSI too high?
The Consultant & Investment Group's current 9-Day RSI is 33.64. The Healthcare Providers & Services industry median 9-Day RSI is 47.47. The Consultant & Investment Group's value of 33.64 is 29.1% below this industry median. Based on the distribution chart, The Consultant & Investment Group ranks #159 out of 699 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, The Consultant & Investment Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, The Consultant & Investment Group ranks #159 out of 699 companies for 9-Day RSI. This places The Consultant & Investment Group in the top 23% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 47.47. The Consultant & Investment Group's value of 33.64 is 29.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 47.47, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Consultant & Investment Group's current 9-Day RSI of 33.64 is 29.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 47.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Consultant & Investment Group's current 9-Day RSI is 33.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.20, compared to a current price of JOD1.78 — trading 19.1% below its estimated fair value. The current 9-Day RSI is 33.64 and 29.1% below the Healthcare Providers & Services industry median of 47.47. The Consultant & Investment Group's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current 9-Day RSI is 33.64 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?
Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued.
The current stock price of JOD1.78 is trading 19.1% below its estimated GF Value™ of JOD2.20.
GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.
Key valuation signals for AMM:CICO:
9-Day RSI: 33.64
GF Value™: JOD2.20 vs. price of JOD1.78 (19.1% below fair value)
Industry Position: 29.1% below the Healthcare Providers & Services median (#159 of 699)
No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Consultant & Investment Group Business Description
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
77GF Score
Get the complete analysis for AMM:CICO
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:CICO has been successfully added to your 